Zentalis Pharmaceuticals
ZNTL
$11.06
Share price
0.68%
Change (1 day)
-49.80%
Change (1 year)
Categories
Operating Margin for Zentalis Pharmaceuticals (ZNTL)
Operating Margin at the end of 2018: -167,342.86%
According to Zentalis Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is -167,343.00%. At the end of 2018 the company had an Operating Margin of -167,342.86%.
Operating Margin history for Zentalis Pharmaceuticals from 2018 to 2018
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2018 | -167,342.86% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | -36.36% | -99.98% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | -8,391.15% | -94.99% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.